SCHEMBL5015809

SCHEMBL5015809

CC(C)(OC([O])=O)C(Cl)(Cl)Cl

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL291087 0.80 THRB (0.35) THRB
SCHEMBL11146755 0.79 CA4 (0.35) THRB
SCHEMBL56282 0.78 THRB (0.33) THRB
SCHEMBL291088 0.78 ALDH1A1 (0.33) THRB
SCHEMBL13434035 0.78 GAA (0.42) THRB
SCHEMBL20109904 0.76 ELANE (0.32) THRB
SCHEMBL80733 0.76 LMNA (0.35) THRB
SCHEMBL16823234 0.76 THRB (0.32) THRB
SCHEMBL13201625 0.74 THRB (0.30) THRB
SCHEMBL8819950 0.74 L3MBTL1 (0.35) THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7427679-B2 Precursors for two-step polynucleotide synthesis AGILENT TECHNOLOGIES, INC. (US) 2008-09-23 US disclosed
US-7417139-B2 Method for polynucleotide synthesis AGILENT TECHNOLOGIES, INC. (US) 2008-08-26 US disclosed
US-7193077-B2 Exocyclic amine triaryl methyl protecting groups in two-step polynucleotide synthesis AGILENT TECHNOLOGIES, INC. (US) 2007-03-20 US disclosed
EP-1512691-A1 Protecting groups for two-step polynucleotide synthesis Agilent Technologies Inc (US) 2005-03-09 EP disclosed
US-20050048601-A1 Method for polynucleotide synthesis REGENTS OF THE UNIVERSITY OF COLORADO, THE 2005-03-03 US disclosed
US-20050049411-A1 Exocyclic amine triaryl methyl protecting groups in two step polynucleotide synthesis REGENTS OF THE UNIVERSITY OF COLORADO, THE 2005-03-03 US disclosed
US-20050049407-A1 Precursors for two-step polynucleotide synthesis THE REGENTS OF THE UNIVERSITY OF COLORADO 2005-03-03 US disclosed
EP-1510523-A1 Precurors for two-step polynucleotide synthesis Agilent Technologies Inc (US) 2005-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050048601-A1 Method for polynucleotide synthesis POLN, RNGTT, NSUN2 THRB 3282/4885
US-20050049407-A1 Precursors for two-step polynucleotide synthesis NT5C3B, NSUN2, POLN THRB 2671/4885
US-20050049411-A1 Exocyclic amine triaryl methyl protecting groups in two step polynucleotide synthesis NT5C3B, RNMT, NSUN2 THRB 2067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.